Home
>
Stock Market
>
>
Cohance Lifesciences Ltd

Cohance Lifesciences Ltd share price and stock overview

Cohance Lifesciences Ltd (NSE: COHANCE, BSE: 543064) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE03QK01018 and a face value of Rs 1. As of 10 November 2026, it trades at Rs (443.65) with a market capitalisation of Rs 16963.59 crore. Figures are live and subject to change.

Cohance Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

443.65 1.65 (0.37%) upARrowC

As on: 10-Nov-2026 , 04:35 PM

Market Cap(₹Cr) 16963.59

Book Value(₹Cr) 117.856823

BSE Code : 543064 NSE Symbol : COHANCE EPS(TTM) : 2.88 ISIN Demat : INE03QK01018 P/E(TTM) : 153.94 Face Value(₹) : 1 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

81,339.41

Todday's Low

80,519.31

Open at

81,327.29

Previous Close

80,999.40

Volumes

Avg Price

107.25

Historical Performance

News

07 Nov 26

Cohance Lifesciences Ltd consolidated sales up 12.88% on year in Q2FY2027

Cohance Lifesciences Ltd share price slipped 3.59% to Rs 433.55 after the company's net profit tanked by 105.

26 Oct 26

Cohance Lifesciences to review financial results at a board meeting November 6, 2026

Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, will hold a board meeting on Friday, November 6, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026, the company informed the Bombay Stock Exchange and National Stock Exchange of India.

07 Oct 26

Cohance Lifesciences files certificates with BSE and NSE, complying with SEBI regulations

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited, submitted Confirmation Certificates issued by KFin Technologies Limited, its Registrar and Share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, to the BSE Limited and National Stock Exchange of India Limited.

28 Sep 26

Cohance Lifesciences halts trading for insiders pending financial results declaration

Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
09-11-26	439.05	448.55	429.00	443.65	889725	32467	393426155.05	25044.65
08-11-26	415.00	444.80	415.00	442.00	347006	7863	151656498.35	24986.40
06-11-26	440.00	443.65	425.00	433.55	792969	28832	344795297.10	25030.35
05-11-26	453.80	458.20	446.95	449.00	336195	16621	152338801.35	24536.60
04-11-26	440.05	451.75	436.15	450.45	237522	13240	105950422.95	23960.60
03-11-26	450.00	453.15	438.50	440.35	330046	20627	146899284.05	23810.85
02-11-26	446.00	450.85	436.85	447.05	498967	19888	222380812.65	23440.80
30-10-26	478.00	481.30	442.15	444.30	1497286	62928	678972740.00	23053.10
29-10-26	476.20	493.05	473.20	481.35	1495780	66677	724035283.70	22936.75
28-10-26	484.00	487.40	471.70	476.05	627122	31039	300513990.35	22698.85

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

16963.59

PE Ratio

153.94

PB Ratio

3.76

Dividend Yield

ROE

5.23

ROCE

7.31

Book Value (₹)

117.856823

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	219930170	57.48	219930170	2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

219930170

57.48

219930170

Indian

Bodies Corporate-Indian (Promoter & Group)	0	0.00	0	0
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	0	0.00	0	0
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

0.00

Total ShareHolding for Promoter & Group

219930170

57.48

219930170

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	211	0.00	211	2
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	29484702	7.71	29484702	97
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	6792776	1.78	6792776	3
Mutual Funds / UTI	64782816	16.93	64746816	25
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	578851	0.15	578851	10
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

101639356

26.57

101603356

137

Non Institution

Bodies Corporate	28800839	7.53	28796839	593
Clearing Members	30	0.00	30	1
Directors & their Relatives	118	0.00	118	1
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	2112510	0.55	2112510	2320
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	979131	0.26	978631	1637
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	930499	0.24	930499	3
Individuals holding nominal share capital up to Rs. 1 lakh	27747119	7.25	27471057	89143
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	2629	0.00	2629	7
Others	420023	0.11	420023	1

Sub Total

61027804

15.95

60747242

93707

Total Public Shareholding

162667160

42.52

162350598

93844

Total of Promoter & Public ShareHolding

382597330

100.00

382280768

93846

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

382597330

100.00

382280768

93846

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	2,268.55	2,608.50	1,051.35	1,340.33	1,320.22
OPM (%)	10.43	25.24	38.59	41.76	50.57
OP	236.51	658.41	405.67	559.73	667.59
Other Income	34.09	69.21	61.91	46.36	92.38
PBIDT	431.61	850.49	467.72	620.53	712.92
INTEREST	37.24	41.06	7.45	12.81	6.23
PBDT	394.37	809.43	460.27	607.72	706.69
PBT	177.57	626.85	405.67	559.73	667.59
EO	-29.47	-15.78	0.00	0.00	0.00
PBT after EO	207.04	642.63	405.67	559.73	667.59
TAXES	56.92	158.39	105.39	148.44	213.78
PAT	179.23	487.34	300.28	411.29	453.80
EPS	4.68	12.68	11.80	16.60	17.83
Raw Material	31.09	27.22	25.29	32.09	34.80
Power and Fuel	5.40	4.12	4.59	5.52	4.51
Employee Cost	22.38	17.17	12.93	8.82	7.61
Other Manufacturing Expenses	2.49	1.67	1.51	1.46	1.30
Selling and Administration Expenses	8.95	5.22	4.95	5.12	6.42
Miscellaneous Expenses	2.89	3.47	1.76	1.01	1.02
Revenue (Growth %)	-13.03	148.11	-21.56	1.52	30.75
PBIDT (Growth %)	-49.25	81.84	-24.63	-12.96	40.21
PAT (Growth %)	-63.22	62.29	-26.99	-9.37	25.24
PBIDT (Margin %)	19.03	32.60	44.49	46.30	54.00
PAT (Margin %)	7.90	18.68	28.56	30.69	34.37

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	38.26	25.46	25.46	25.46	25.46	25.46
Reserves Total	4441.85	4223.34	2002.89	1723.92	1495.24	1039.73
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	18.97	0.00	0.00	0.00	0.00
Total Shareholders Funds	4480.11	4267.77	2028.35	1749.38	1520.70	1065.19
Secured Loans	95.24	250.23	38.58	69.16	95.57	99.78
Unsecured Loans	50.39	55.27	26.43	1.18	1.55	43.26
Total Debt	145.63	305.50	65.01	70.34	97.12	143.04
Other Liabilities	0.00	0.00	0.00	7.87	8.89	6.65
Total Liabilities	4625.74	4573.27	2093.36	1827.59	1626.71	1214.88
APPLICATION OF FUNDS :
Gross Block	3068.97	2739.28	928.90	713.00	694.97	568.76
Less : Accumulated Depreciation	781.09	660.62	259.28	200.98	160.77	127.60
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2287.88	2078.66	669.62	512.02	534.20	441.16
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	145.80	332.75	179.08	164.81	29.99	96.32
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1186.63	1116.68	892.57	710.06	599.90	426.24
Current Assets, Loans & Advances
Inventories	540.13	454.92	231.20	311.47	283.42	201.08
Sundry Debtors	641.61	730.15	133.66	109.66	236.37	102.38
Cash and Bank Balance	19.99	36.42	21.73	46.23	32.95	9.56
Loans and Advances	205.57	200.46	63.74	94.91	75.00	71.07
Total Current Assets	1407.30	1421.95	450.33	562.27	627.74	384.10
Less : Current Liabilities and Provisions
Current Liabilities	387.67	366.94	58.34	84.93	133.06	110.42
Provisions	61.11	50.42	15.04	4.16	7.72	2.61
Total Current Liabilities & Provisions	448.78	417.36	73.38	89.10	140.78	113.03
Net Current Assets	958.52	1004.59	376.95	473.17	486.96	271.07
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	76.24	60.07	11.59	1.40	1.47	2.47
Deferred Tax Liability	114.92	106.49	58.92	43.05	38.87	33.40
Net Deferred Tax	-38.68	-46.42	-47.33	-41.65	-37.40	-30.93
Other Assets	85.59	87.01	22.47	9.16	13.07	11.01
Total Assets	4625.74	4573.27	2093.36	1827.58	1626.72	1214.87
Contingent Liabilities	127.74	57.92	18.11	6.07	6.07	25.52

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-156.41	-243.14	-39.99	-309.91	-202.78
Investing Activities	-90.36	-236.86	-362.40	-455.26	-204.29
Net Cash Flow	23.12	12.81	-26.19	-78.94	-17.50
Operating Activities	269.89	492.82	376.20	686.23	389.57

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

921.40

(-0.89%)

Accent Microcell...

602.70

(-2.79%)

Accretion Pharma...

203.15

(-3.26%)

Achyut Healthcar...

Advanced Enzyme ...

282.10

(-0.74%)

Akums Drugs & Ph...

765.85

(+2.96%)

Albert David Ltd

800.90

(+0.89%)

Alembic Pharmace...

1,017.30

(+0.72%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

Umang Vohra

Chairman & Group CEO

Executive

Functional Directors

Shweta Jalan

Non Executive Director

Exec.

Pankaj Patwari

Non Executive Director

Exec.

Independent Directors

Vinod Padikkal

Non-Exec & Non-Independent Dir

Ind.

Matangi Gowrishankar

Independent Non Exe. Director

Ind.

Vinod Rao

Independent Non Exe. Director

Ind.

KGA

K G Ananthakrishnan

Independent Non Exe. Director

Ind.

UBP

U B Pravin Rao

Independent Non Exe. Director

Ind.

Jaishankar Krishnan

Independent Non Exe. Director

Ind.

Other Officials

SKM

S. K. Mishra

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Cohance Lifesciences Ltd? −

Cohance Lifesciences Ltd trades on NSE under COHANCE and on BSE under code 543064. The ISIN is INE03QK01018 and the face value is Rs 1.

What is the share price of Cohance Lifesciences Ltd today? +

As of 10 November 2026, Cohance Lifesciences Ltd trades at Rs 443.65, a change of 1.65 (0.37%) on the day. Prices are live and subject to change.

What is the market capitalisation of Cohance Lifesciences Ltd? +

As of 10 November 2026, Cohance Lifesciences Ltd has a market cap of about Rs 16963.59 crore. This figure is live and moves with the share price.

Is Cohance Lifesciences Ltd profitable? +

In March 2026, Cohance Lifesciences Ltd reported a profit after tax of Rs 179.23 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Cohance Lifesciences Ltd? +

: As of 10 November 2026, the PE (TTM) for Cohance Lifesciences Ltd is 153.94 and the price-to-book ratio is 3.76. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Cohance Lifesciences Ltd pay a dividend? +

As of 10 November 2026, the dividend yield for Cohance Lifesciences Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Cohance Lifesciences Ltd? +

As of the latest disclosed pattern, promoters hold 57.48% of Cohance Lifesciences Ltd. Public shareholding is 42.52%, including mutual funds at 16.93% and foreign institutional investors at 7.71%.

What were the latest annual financials of Cohance Lifesciences Ltd? +

In March 2026, Cohance Lifesciences Ltd reported net sales of Rs 2,268.55 crore, revenue growth of -13.03%, and earnings per share of Rs 4.68.